Preterm Risk

Fetal Fibronectin (fFN) Rapid Test (Vaginal Secretion Swab)

Rapid detection of fetal fibronectin (fFN) in vaginal secretions.

CE Certified
ISO 13485
Main image of Fetal Fibronectin (fFN) Rapid Test (Vaginal Secretion Swab)

Why Choose reOpenTest Women's Health & Reproduction Kits?

Our tests are engineered for accuracy, reliability, and ease of use, ensuring confidence in every result.

Timely Intervention

Allows for timely interventions to reduce the likelihood of preterm birth.

Point-of-Care

Provides quick results at the point-of-care, facilitating prompt decision-making.

Risk Assessment

Valuable tool for risk assessment of preterm delivery between 24 and 34 weeks.

Product Overview

The Fetal Fibronectin (fFN) Rapid Test detects fetal fibronectin in vaginal secretions between 24 and 34 weeks of gestation, indicating an increased risk of preterm delivery within two weeks. Provides healthcare professionals with a valuable risk assessment tool.

Technical Specifications

Detection Target Fetal Fibronectin (fFN)
Sample Type Vaginal Secretion Swab
Methodology Immunochromatographic assay
Detection Range Positive/Negative
Reaction Time 10-15 minutes
Storage Conditions 2-30u00b0C
Shelf Life 18 months

Procedure & Interpretation

Step-by-Step Procedure

  1. Collect vaginal secretion sample using the provided swab.
  2. Apply sample to the test device.
  3. Wait 10-15 minutes.
  4. Read and interpret the results.

Result Interpretation

Positive Result
Positive: A colored band appears, indicating the presence of fFN and increased risk of preterm delivery.
Negative Result
Negative: No colored band appears, indicating a low risk of preterm delivery.
Invalid Result
Invalid: If no bands appear, or control band is absent, the test is invalid and needs repeating.

Frequently Asked Questions

A positive fFN result suggests an increased risk of preterm delivery within the next two weeks, warranting close monitoring and potential interventions.

fFN is a glycoprotein found in fetal membranes, and its presence in vaginal secretions indicates a disruption between the fetal membranes and the uterine lining.

The test is specifically designed for women between 24 and 34 weeks of gestation who are experiencing symptoms of preterm labor.

Technical Documents

Download product inserts and brochures for detailed information.

No technical documents are available at this time. Please check back soon.

Partner with reOpenTest

Provide your clients and patients with reliable diagnostic solutions.
Contact us today for bulk pricing and distribution opportunities.

Become a Distributor